Prof. Dr. Bahar ARTIM ESEN

Yayın Ağı

Makaleler 103

1. Association of HLA Genes With Early Onset and Adult Systemic Lupus Erythematosus Disease in Turkish Population

ŞENTÜRK ÇİFTÇİ H., Sahin S., KIVANÇ D., Dogan S., Mahmutbegovic A., Demirbas K. C., et al.

HLA , cilt.105, 2025 (SCI-Expanded)

2. Mortality and associated factors in patients with systemic sclerosis-associated pulmonary hypertension with and without interstitial lung disease: A long-term follow-up study

AMIKISHIYEV S., YALÇINKAYA Y., Mammadova K., Aliyeva N., DURAK G., Artim-Esen B., et al.

MODERN RHEUMATOLOGY , 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

3. Prevalence and target attainment of traditional cardiovascular risk factors in patients with systemic lupus erythematosus: a cross-sectional study including 3401 individuals from 24 countries

Bolla E., Semb A. G., Kerola A. M., Ikdahl E., Petri M., Pons-Estel G. J., et al.

The Lancet Rheumatology , cilt.6, sa.7, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

4. Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository (“Registry”)

Yelnik C. M., Erton Z. B., Drumez E., Cheildze D., de Andrade D., Clarke A., et al.

Seminars in Arthritis and Rheumatism , cilt.65, 2024 (SCI-Expanded)

5. Utility of positron emission tomography as a new tool for muscle involvement in patients with idiopathic inflammatory myositis: a controlled study

BEKTAŞ M., IŞIK E. G., Oguz E., Kemik F., Abbasgholizadeh A., İNCE B., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.42, sa.2, ss.358-366, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

6. Serum and urine interferon-inducible protein 10, galectin-9, and SIGLEC-1 as biomarkers of disease activity in systemic lupus erythematosus

Mirioğlu Ş., Çınar S., Uludağ Ö., Gürel E., Varelci S., Özlük Y., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.54, sa.2, ss.391-400, 2024 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

7. 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria

Barbhaiya M., Zuily S., Naden R., Hendry A., Manneville F., Amigo M., et al.

Arthritis and Rheumatology , cilt.75, sa.10, ss.1687-1702, 2023 (SCI-Expanded)

8. Phenotypes of the Patients with More Than One Autoinflammatory Gene Variant: Classified Diseases and Mixed Autoinflammatory Disorders (MAID)

Amıkıshıyev S., Kalaycı T., Soltanova L., Yalçınkaya Y., Artim-Esen B., İnanç M., et al.

ARTHRITIS & RHEUMATOLOGY , ss.506-508, 2023 (SCI-Expanded)

9. **Clinical Features of the Patients with NLRP1 Gene Variants and a Systemic Autoinflammatory Phenotype**

AMIKISHIYEV S., KALAYCI T., Deniz R., YALÇINKAYA Y., ARTIM ESEN B., İNANÇ M., et al.

ARTHRITIS & RHEUMATOLOGY , ss.3800-3802, 2023 (SCI-Expanded)

10. Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry

Balbi G. G. M., Ahmadzadeh Y., Tektonidou M. G., Pengo V., Sciascia S., Ugarte A., et al.

RHEUMATOLOGY , 2023 (SCI-Expanded)

11. Thrombotic risk assessment in antiphospholipid syndrome: do noncriteria antibodies contribute?

Uludağ Ö., ÇINAR S., McDonnell T., ÇENE E., Yalçinkaya Y., GÜL A., et al.

Turkish Journal of Medical Sciences , cilt.53, sa.5, ss.1067-1074, 2023 (SCI-Expanded)

12. Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry")

Erton Z. B., Leaf R. K., de Andrade D., Clarke A. E., Tektonidou M. G., Pengo V., et al.

LUPUS , cilt.31, sa.14, ss.1770-1776, 2022 (SCI-Expanded)

13. Single Antiphospholipid Antibody Positive Thrombotic APS Patients' Clinical Characteristics: Retrospective Results from the APS ACTION Clinical Database and Repository (Registry)

Foddai S. G., Cecchi I., Radin M., De Andrade D., Tektonidou M., Pengo V., et al.

ARTHRITIS & RHEUMATOLOGY , ss.1366-1368, 2022 (SCI-Expanded)

14. Thrombocytopenia and Autoimmune Hemolytic Anemia in Antiphospholipid Antibody-positive Patients: Descriptive Analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry")

Erton Z. B., Leaf R. K., de Andrade D. C. O., Barber M., Tektonidou M. G., Pengo V., et al.

ARTHRITIS & RHEUMATOLOGY , ss.1340-1342, 2022 (SCI-Expanded)

15. Recurrent Thrombosis Risk in Non-anticoagulated Antiphospholipid Syndrome Patients: A Prospective Case-Control Study from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry")

Yelnik C., Erton Z. B., Drumez E., Cheildze D., Oliveira de Andrade D. C., Clarke A. E., et al.

ARTHRITIS & RHEUMATOLOGY , ss.4510-4513, 2022 (SCI-Expanded)

16. ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients Without Other Systemic Autoimmune Diseases: Clinical and Serological Characteristics, Results from the APS ACTION Clinical Database and Repository

Cecchi I., Radin M., Foddai S. G., Bertolaccini M. L., De Andrade D., Tektonidou M., et al.

ARTHRITIS & RHEUMATOLOGY , ss.1365-1366, 2022 (SCI-Expanded)

17. Antibodies to FXa and thrombin in patients with SLE differentially regulate C3 and C5 cleavage

McDonnell T., Amarnani R., Spicer C., Jbari H., Pericleous C., Spiteri V. A., et al.

Lupus Science and Medicine , cilt.9, sa.1, 2022 (SCI-Expanded)

18. DIFFERENCES IN THE CLINICAL SPECTRUM OF HAPLOINSUFFICIENCY OF A20 (HA20) CASES DIAGNOSED DURING ADULTHOOD

Amikishiyev S., Aliyeva N., Bektas M., Koca N., Soltanova L., Yalcinkaya Y., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1756, 2022 (SCI-Expanded)

19. VASCULAR EVENTS AND ASSOCIATED FACTORS IN ANCA-ASSOCIATED VASCULITIS: ANALYSIS OF 237 PATIENTS WITH LONG-TERM FOLLOW-UP

BEKTAŞ M., İNCE B., ZARALI S., GÜLSEREN Ü. A., ÜK E., YALÇINKAYA Y., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1432-1433, 2022 (SCI-Expanded)

20. SERUM AND URINE GALECTIN-9, IP-10 AND SIGLEC-1 AS BIOMARKERS OF DISEASE ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Mirioglu S., Cinar S., Uludag O., Gurel E., Varelci S., Ozluk Y., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1374, 2022 (SCI-Expanded)

21. AMYLOID STORM DEVELOPS IN PATIENTS WITH AA AMYLOIDOSIS AND ASSOCIATED WITH HIGHER AMYLOID BURDEN AND INCREASED MORTALITY

BEKTAŞ M., SARI S., KOCA N., OĞUZ E., İNCE B., YALÇINKAYA Y., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1001, 2022 (SCI-Expanded)

22. DEVELOPMENT OF MALIGNANCY IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS

BEKTAŞ M., İNCE B., ZARALI S., GÜLSEREN Ü. A., ÜK E., AĞARGÜN B. F., et al.

ANNALS OF THE RHEUMATIC DISEASES , ss.1430-1431, 2022 (SCI-Expanded)

23. ANTI-FIBROTIC THERAPY IN PROGRESSIVE PULMONARY FIBROSIS ASSOCIATED WITH SYTEMIC SCLEROSIS: CHARACTERISTICS OF SSC-IAH PATIENTS RECEIVING NINTEDANIB AND ADVERS EVENTS DURING TREATMENT

Yalcinkaya Y., Amikishiyev S., Aliyeva N., Artim-Esen B., Gul A., Bingol Z., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1499, 2022 (SCI-Expanded)

24. AMYLOID BURDEN AND ASSOCIATED FACTORS PREDICT HIGHER MORTALITY AND POOR OUTCOME IN FAMILIAL MEDITERRANEAN FEVER-ASSOCIATED AA AMYLOIDOSIS: DATA FROM A TERTIARY REFERRAL AMYLOIDOSIS CENTER WITH 137 PATIENTS

BEKTAŞ M., KOCA N., OĞUZ E., İNCE B., SARI S., ŞENTÜRK N., et al.

ANNALS OF THE RHEUMATIC DISEASES , ss.348, 2022 (SCI-Expanded)

25. FAVOURABLE COURSE OF COVID-19 IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER USING BIOLOGIC AGENTS

Aliyeva N., Sari S., Amikishiyev S., Dulundu B. C. Y., Suleymanova V., Telli P., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.976-977, 2022 (SCI-Expanded)

26. A Case of Budd-Chiari Syndrome Associated With Antiphospholipid Syndrome Treated Successfully by Transjugular Intrahepatic Portosystemic Shunt

Torun E. S., Erciyestepe M., Yalcinkaya Y., Gul A., Inanc M., Ocal L., et al.

CLINICAL MEDICINE INSIGHTS-CASE REPORTS , cilt.15, 2022 (ESCI)

27. SERUM AND URINE GALECTIN-9, IP-10 AND SIGLEC-1 AS BIOMARKERS OF DISEASE ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS COMPARED TO ANCA-ASSOCIATED VASCULITIS: A LONGITUDINAL STUDY

Mirioglu Ş., Cinar S., Uludag O., Gurel E., Varelci S., Ozluk Y., et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION , cilt.37, 2022 (SCI-Expanded, Scopus)

28. EFFECTS OF SMOKING IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS RECEIVING TUMOR NECROSIS FACTOR INHIBITORS THERAPY

Pehlivan O., Yalcinkaya Y., Artim Esen B., Huseyinsinoglu N., Gül A., Inanc M., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.85, sa.3, ss.362-369, 2022 (ESCI)

29. Genetic screening of early-onset patients with systemic lupus erythematosus by a targeted next-generation sequencing gene panel

Dasdemir S., Yildiz M., Celebi D., Şahin S., Aliyeva N., Haşlak F., et al.

LUPUS , cilt.31, sa.3, ss.330-337, 2022 (SCI-Expanded)

30. Chronic oxcarbazepine intoxication in a patient with primary antiphospholipid syndrome on maintenance haemodialysis

Dirim A. B., MİRİOĞLU Ş., Yesilot N., Oguz E., Yazici H., Inanc M., et al.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , cilt.47, sa.2, ss.257-259, 2022 (SCI-Expanded)

31. A Case of Takayasu Arteritis with Thrombotic Microangiopathy Secondary to Malignant Hypertension Due to Bilateral Renal Artery Stenosis

Torun E. S., Koca N., Yalcinkaya Y., Esen B. A., Gül A., Inanc M.

OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS , cilt.14, ss.39-42, 2022 (ESCI)

32. Interstitial lung disease in patients with systemic lupus erythematosus: a cohort study

Senkal N., Kiyan E., Demir A. A., Yalcinkaya Y., Gül A., Inanc M., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.52, sa.1, ss.76-82, 2022 (SCI-Expanded)

33. Ankilozan spondilit ve psöriyatik artritte sekukinumab deneyimi: Tek merkezden 44 hastanın analizi

BEKTAŞ M., ÇETİN Ç., YALÇINKAYA Y., ESEN B. A., ÖCAL L., GÜL A., et al.

Ulusal Romatoloji Dergisi , cilt.13, sa.3, ss.116-120, 2021 (Hakemli Dergi)

34. A shared motif of hla-dpb1 affecting the susceptibility to pr3-anca positive granulomatosis with polyangiitis: comparative analysis of a Turkish cohort with matched healthy controls

Ince B., Kamali S., Bektas M., Ogret Y., Savran F., Yalcinkaya Y., et al.

RHEUMATOLOGY INTERNATIONAL , sa.9, ss.1667-1672, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

35. Symptomatic osteonecrosis of the hip and knee in patients with systemic lupus erythematosus: Prevalence, pattern, and comparison of natural course

Ersin M., Demirel M., Ekinci M., Mert L., cetin C., Artim Esen B., et al.

LUPUS , cilt.30, ss.1603-1608, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

36. HYPOGAMMAGLOBULINEMIA IS A SIGNIFICANT RISK FACTOR FOR MORTALITY IN PATIENTS WITH ANCA ASSOCIATED VASCULITIS AND COVID-19

İNCE B., BEKTAŞ M., KOCA N., AĞARGÜN B. F., ZARALI S., Guzey D. Y., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.912-913, 2021 (SCI-Expanded)

37. EVALUATION OF BASELINE POSITRON EMISSION TOMOGRAPHY IN THE DIAGNOSIS AND ASSESSMENT OF GIANT CELL ARTERITIS

Ince B., Isik E. G., Ozkan Z. G., Yalcinkaya Y., Artim-Esen B., Gul A., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.1210-1211, 2021 (SCI-Expanded)

38. ANALYSIS OF 5-YEAR HOSPITALIZATION DATA OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: DAMAGE IS A RISK FACTOR FOR FREQUENT AND LONGER STAYS

Çetin Ç., Can M. G., Öztaşkın S., Yalçınkaya Y., Gül A., İnanç M., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.604-605, 2021 (SCI-Expanded)

39. MORE FREQUENT AND EARLIER HIP INVOLVEMENT IN SPONDYLOARTHRITIS ASSOCIATED WITH FAMILIAL MEDITERRANEAN FEVER

BEKTAŞ M., SARI S., ÇETİN Ç., Dulundu B. C. Y., KOCA N., İNCE B., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.951-952, 2021 (SCI-Expanded)

40. PERFORMANCES OF DIFFERENT CLASSIFICATION CRITERIA FOR SYSTEMIC LUPUS ERYTHEMATOSUS IN A SINGLE CENTER COHORT FROM TURKEY

TORUN E. S., BEKTAŞ E., KEMİK F., BEKTAŞ M., ÇETİN Ç., YALÇINKAYA Y., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.602-603, 2021 (SCI-Expanded)

41. RETINOL BINDING PROTEIN 4 AS AN ACUTE PHASE REACTANT AND BIOMARKER IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER AND AMYLOIDOSIS COMPARED TO INFECTIONS

Koca N., Deniz R., Erdugan M., Yalcinkaya Y., Artim-Esen B., Ocal M. L., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.1006-1007, 2021 (SCI-Expanded)

42. PULMONARY INVOLVEMENT IN A SINGLE CENTER COHORT OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Senkal N., Kiyan E., Kocasoy-Orhan E., Demir A., Aydoğan S. M., Yalcinkaya Y., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.1191, 2021 (SCI-Expanded)

43. SYSTEMIC SCLEROSIS ASSOCIATED PULMONARY ARTERIAL HYPERTENSION: PREDOMINANCE OF PULMONARY FIBROSIS AS A RISK FACTOR FOR MORTALITY IN A SINGLE CENTER COHORT

Amikishiyev S., Yalcinkaya Y., Aliyeva N., Mammadova K., Artim-Esen B., Gul A., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.1251-1252, 2021 (SCI-Expanded)

44. CLUSTER ANALYSIS AND COMPARISON OF CUMULATIVE DAMAGE BY DIAPS IN A SINGLE CENTER COHORT OF APS PATIENTS

ULUDAĞ Ö., GÜREL E., ÇETİN Ç., ÇENE E., YALÇINKAYA Y., GÜL A., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.636-637, 2021 (SCI-Expanded, Scopus)

45. Tümör nekrozis faktör-alfa inhibitörü tedavisi gereken aksiyal spondiloartritli kadın hastalarda klinik özellikler ve tedavi sonuçları

YALÇINKAYA Y., PEHLİVAN Ö., HÜSEYİNSİNOĞLU N., ALİYEVA N., AMIKISHIYEV S., ESEN B. A., et al.

Ulusal Romatoloji Dergisi , cilt.13, sa.3, ss.100-106, 2021 (Hakemli Dergi)

46. Long-term follow-up of 89 patients with giant cell arteritis: a retrospective observational study on disease characteristics, flares and organ damage

Ince B., Artan S., Yalcinkaya Y., Artim-Esen B., Gül A., Ocal L., et al.

RHEUMATOLOGY INTERNATIONAL , sa.2, ss.439-448, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

47. Validation of the adjusted global antiphospholipid syndrome score in a single centre cohort of APS patients from Turkey.

Uludağ Ö., Bektaş M., Cene E., Sezer M., Sahinkaya Y., Gül A., et al.

Journal of thrombosis and thrombolysis , cilt.51, sa.2, ss.466-474, 2021 (SCI-Expanded)

48. Femoral vein wall thickness measurement: A new diagnostic tool for Behcet's disease

ALİBAZ ÖNER F., ERGELEN R., YILDIZ Y., Aldag M., YAZICI A., ÇEFLE A., et al.

RHEUMATOLOGY , cilt.60, sa.1, ss.288-296, 2021 (SCI-Expanded)

49. Antifosfolipid sendromunda kardiyovasküler risk: Trombotik ve obstetrik hastalık alt gruplarının karşılaştırılması

ULUDAĞ Ö., YALÇINKAYA Y., GÜL A., İNANÇ M., ÖCAL L., ESEN B. A.

Ulusal Romatoloji Dergisi , cilt.12, sa.3, ss.83-87, 2020 (Hakemli Dergi)

50. Pulmonary Involvement in a Single Center Cohort of Patients with Systemic Lupus Erythematosus

Senkal N., KIYAN E., Kocasoy-Orhan E., Demir A., AYDOĞAN M., YALÇINKAYA Y., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.72, 2020 (SCI-Expanded)

51. Serum and urine TNF-like weak inducer of apoptosis, monocyte chemoattractant protein-1 and neutrophil gelatinase-associated lipocalin as biomarkers of disease activity in patients with systemic lupus erythematosus

Mirioğlu Ş., Çınar S., Yazıcı H., Özlük Y., Kılıçaslan I., Gül A., et al.

LUPUS , sa.4, ss.379-388, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

52. The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort

Radın M., Sciascia S., Erkan D., Pengo V., Tektonıdou M. G., Ugarte A., et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM , cilt.49, ss.464-468, 2019 (SCI-Expanded)

53. Assessment of Femoral Vein Wall Thickness with Doppler Ultrasound Can Be a Diagnostic Tool for Behcet's Disease

ALİBAZ ÖNER F., ERGELEN R., YILDIZ Y., YAZICI A., Mutis A., Erturk Z., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.71, 2019 (SCI-Expanded)

54. Autoimmune haemolytic anaemia and thrombocytopaenia in a single-centre cohort of patients with systemic lupus erythematosus from Turkey: clinical associations and effect on disease damage and survival

Artim-Esen B., Çene E., Sahinkaya Y., Erdugan M., Oguz E., Gül A., et al.

LUPUS , cilt.28, sa.12, ss.1480-1487, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

55. Association of Serum and Urine Levels of TWEAK, MCP-1 and NGAL with Disease Activity in Systemic Lupus Erythematosus

Mirioglu S., ÇINAR S., YAZICI H., GÜL A., Ocal L., İNANÇ M., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.71, 2019 (SCI-Expanded)

56. Clinical course of abdominal aortic aneurysms in Behcet disease: a retrospective analysis

Sahutoglu T., Esen B. A., Aksoy M., Kurtoglu M., Poyanli A., Gül A.

RHEUMATOLOGY INTERNATIONAL , cilt.39, sa.6, ss.1061-1067, 2019 (SCI-Expanded)

57. Domain I of beta 2GPI is capable of blocking serum IgA antiphospholipid antibodies binding in vitro: an effect enhanced by PEGylation

Albay A., Artim-Esen B., PERICLEOUS C., Wincup C., Giles I., Rahman A., et al.

LUPUS , cilt.28, sa.7, ss.893-897, 2019 (SCI-Expanded)

58. Antiphospholipid Antibodies to Domain I of Beta-2-Glycoprotein I Show Different Subclass Predominance in Comparison to Antibodies to Whole Beta-2-glycoprotein I

McDonnell T., Artim-Esen B., Wincup C., Ripoll V. M., Isenberg D., Giles I. P., et al.

FRONTIERS IN IMMUNOLOGY , cilt.9, 2018 (SCI-Expanded)

59. Classification of Idiopathic Inflammatory Myopathies: Assessment of 123 Patients According to 2017 Acr/EULAR Criteria Followed up By a Single Center from Turkey

Oguz E., Sahin E., Erdugan M., Artim-Esen B., Gül A., Ocal L., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded)

60. Increased serum leptin levels are associated with metabolic syndrome and carotid intima media thickness in premenopausal systemic lupus erythematosus patients without clinical atherosclerotic vascular events

Demir S., Erten G., Artim-Esen B., Sahinkaya Y., Pehlivan Ö., Alpay-Kanitez N., et al.

LUPUS , cilt.27, sa.9, ss.1509-1516, 2018 (SCI-Expanded, Scopus)

61. Influence of smoking on the manifestations at the onset and course of Behcet disease

Aydin M., Artim-Esen B., Inanc M., Ocal L., Gul A.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.6, 2018 (SCI-Expanded)

62. Sistemik lupus eritematozus'da hastalık aktivitesinin değerlendirilmesi ve aktivite indeksleri

Artım Esen B.

RAED , cilt.10, sa.1, ss.6-13, 2017 (Hakemli Dergi)

63. Factor Xa Mediates Calcium Flux in Endothelial Cells and is Potentiated by Igg From Patients With Lupus and/or Antiphospholipid Syndrome

Artim-Esen B., Smoktunowicz N., McDonnell T., Ripoll V. M., Pericleous C., Mackie I., et al.

SCIENTIFIC REPORTS , cilt.7, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

64. Comparison of Disease Characteristics, Organ Damage, and Survival in Patients with Juvenile-onset and Adult-onset Systemic Lupus Erythematosus in a Combined Cohort from 2 Tertiary Centers in Turkey.

Artim-Esen B., Sahin S., Çene E., Sahinkaya Y., Barut K., Adrovic A., et al.

The Journal of rheumatology , cilt.44, sa.5, ss.619-625, 2017 (SCI-Expanded)

65. Capillaroscopic findings and vascular biomarkers in systemic sclerosis: Association of low CD40L levels with late scleroderma pattern

Yalcinkaya Y., Adin-Cinar S., Artim-Esen B., Kamali S., Pehlivan O., Ocal L., et al.

MICROVASCULAR RESEARCH , cilt.108, ss.17-21, 2016 (SCI-Expanded, Scopus)

66. Efficacy of Colchicine and IL-1 Inhibitors in Amyloidosis Associated with Familial Mediterranean Fever: A Retrospective Analysis

Toz B., Tecer S., Oguz E., Erdugan M., Artim-Esen B., Kamali S., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded)

67. a Singlecenter Experience of Rituximab Treatment in 86 Patients with Systemic Lupus Erythematosus

Artim-Esen B., Toz B., Erer B., Kamali S., Gül A., Ocal L., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded)

68. Microscopic colitis in patients with Takayasu's arteritis: a potential association between the two disease entities.

Kanitez N. A., Toz B., Gulluoglu M., Erer B., Esen B. A., Omma A., et al.

Clinical rheumatology , cilt.35, sa.10, ss.2495-9, 2016 (SCI-Expanded)

69. the Prevalence and Associations of IgG/a/M ANTI-beta 2GPI and ANTI-Domain I Antibodies in an Antiphospholipid Syndrome (APS) Cohort of Patients from Turkey

Artim-Esen B., McDonnell T., Pericleous C., Pehlivan O., Inanc M., Giles I., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded)

70. The relationship between vascular biomarkers and disease characteristics in systemic sclerosis: elevated MCP-1 is predominantly associated with fibrotic manifestations

Yalcinkaya Y., Cinar S., Artim-Esen B., Kamali S., Ocal L., Deniz G., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.5, 2016 (SCI-Expanded, Scopus)

71. Metabolic syndrome is not only a risk factor for cardiovascular diseases in systemic lupus erythematosus but is also associated with cumulative organ damage: a cross-sectional analysis of 311 patients

Demir S., Artim-Esen B., Sahinkaya Y., Pehlivan Ö., Alpay-Kanitez N., Omma A., et al.

LUPUS , cilt.25, sa.2, ss.177-184, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

72. Patients with SLE Who Are Anti-Factor Xa IgG Positive Are Less Likely to Have Atherosclerotic Plaque

Murphy C., Croca S., Artim-Esen B., Hanns L., Pericleous C., McDonnell T., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded)

73. Autoimmune Hemolytic Anemia and Thrombocytopenia in a Single Centre Cohort of Patients with Systemic Lupus Erythematosus from Turkey : Clinical Associations and Effect on Disease Damage and Survival

Artim-Esen B., Kamali S., GÜL A., Ocal L., İNANÇ M.

ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded)

74. Anti-factor Xa antibodies in patients with antiphospholipid syndrome and their effects upon coagulation assays.

Artim-Esen B., Pericleous C., Mackie I., Ripoll V. M., Latchman D., Isenberg D., et al.

Arthritis research & therapy , cilt.17, ss.47, 2015 (SCI-Expanded)

75. Favourable pregnancy outcome in Takayasu arteritis: a single-centre experience

Alpay-Kanitez N., Omma A., Erer B., Artim-Esen B., Gül A., Inanc M., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.33, sa.2, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

76. The Significance and Management of Thrombocytopenia in Antiphospholipid Syndrome

Artim-Esen B., DIZ-KUCUKKAYA R., Inanc M.

CURRENT RHEUMATOLOGY REPORTS , cilt.17, sa.3, 2015 (SCI-Expanded)

77. Comparison of Disease Characteristics and Organ Damage in Patients with Juvenile and Adult-Onset Systemic Lupus Erythematosus in Large Cohort from Turkey.

Artim-Esen B., Kasapcopur O., Sahin S., Barut K., Omma A., Sahinkaya Y., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded)

78. Cluster analysis of autoantibodies in 852 patients with systemic lupus erythematosus from a single center.

Artim-Esen B., Çene E., Sahinkaya Y., Ertan S., Pehlivan O., Kamali S., et al.

The Journal of rheumatology , cilt.41, sa.7, ss.1304-10, 2014 (SCI-Expanded)

79. Hastalık modifiye edici ilaçlara ve/veya TNF-alfa antagonistlerine dirençli romatoid artrit hastalarında rituksimabın etkinlik ve güvenliligi: 32 hastanın geriye dönük degerlendirilmesi.

Yalçınkaya (Şahinkaya) Y., Artım Esen B., Pehlıvan Ö., Kamalı S., Aral O., İnanç M.

Ulusal Romatoloji Dergisi , cilt.5, sa.1, ss.1-7, 2013 (Hakemli Dergi)

80. Hastalık modifiye edici ilaçlara ve veya TNF alfa antagonistlerine dirençli romatoid artrit hastalarında rituksimabın etkinlik ve güvenliliği 32 hastanın geriye dönük değerlendirilmesi

YALÇINKAYA Y., ARTIM ESEN B., PEHLİVAN Ö., KAMALI S., ARAL M. O., İNANÇ M.

RAED Dergisi , cilt.5, sa.1, ss.1-7, 2013 (Hakemli Dergi)

81. Coexistence of Familial Mediterranean Fever and Acute Intermittent Porphyria

Akturk F., Caliskan Y., Esen B.

TURKISH JOURNAL OF RHEUMATOLOGY , cilt.27, sa.4, ss.271-272, 2012 (SCI-Expanded)

82. Hemofagositik lenfohistiyositoz ve romatolojik hastalıklar

Artım Esen B.

RAED , cilt.4, sa.2, ss.47-51, 2012 (Hakemli Dergi)

83. Interleukin-1 beta-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study

Gül A., Tugal-Tutkun I., Dınarello C. A., Reznıkov L., Esen B. A., Mırza A., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.71, ss.563-566, 2012 (SCI-Expanded)

84. The impact of platelet membrane glycoprotein Ib alpha and Ia/IIa polymorphisms on the risk of thrombosis in the antiphospholipid syndrome

Yonal I., Hindilerden F., Hancer V. S., Artim-Esen B., Daglar A., Akadam B., et al.

Thrombosis Research , cilt.129, sa.4, ss.486-491, 2012 (SCI-Expanded)

85. Re-evaluation of 129 patients with systemic necrotizing vasculitides by using classification algorithm according to consensus methodology

Kamali S., Artim-Esen B., Erer B., Ozdener L., Gül A., Ocal L., et al.

CLINICAL RHEUMATOLOGY , cilt.31, sa.2, ss.325-328, 2012 (SCI-Expanded)

86. Serologic response to Epstein-Barr virus antigens in patients with systemic lupus erythematosus: a controlled study

Esen B. A., Yilmaz G., Uzun S., Ozdamar M., Aksozek A., Kamali S., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.32, sa.1, ss.79-83, 2012 (SCI-Expanded)

87. Lupus Nefriti ve Tedavisi

Artım Esen B.

Türkiye Klinikleri Dahili Bilimler , cilt.4, sa.3, ss.30-39, 2011 (Hakemli Dergi)

88. Follow-up results of 702 patients receiving tumor necrosis factor-alpha antagonists and evaluation of risk of tuberculosis

Cagatay T., Aydin M., Sunmez S., Cagatay P., Gulbaran Z., Gül A., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.30, sa.11, ss.1459-1463, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

89. The need for blood products in patients with crush syndrome.

KAZANCIOGLU R., PINARBASI B., Esen B., Turkmen A., Sever M. Ş.

American journal of disaster medicine , cilt.5, ss.295-301, 2010 (Scopus)

90. SAFE, RAPID-ONSET, AND SUSTAINED BIOLOGICAL ACTIVITY OF IL-1BETA REGULATING ANTIBODY XOMA 052 IN RESISTANT UVEITIS OF BEHCET'S DISEASE: PRELIMINARY RESULTS OF A PILOT TRIAL

Gül A., Artim-Esen B., Solinger A., Giustino L., Tugal-Tutkun I.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded)

91. PULMONARY PERFUSION SCINTIGRAPHY FINDINGS IN BEHCET'S DISEASE

Cosan F., Adalet I., Artim-esen B., Aral O., Gül A.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded)

92. Persistent arteriosinusoidal coronary fistulae in a patient with hypertrophic cardiomyopathy

Golcuk E., Akdeniz C., Aslanger E. K., Cizgici Y., Esen B., Umman B., et al.

ACTA CARDIOLOGICA , cilt.65, sa.3, ss.371-373, 2010 (SCI-Expanded)

93. The prevalence and clinical significance of inherited thrombophilic risk factors in patients with antiphospholipid syndrome

Diz-Kucukkaya R., Hancer V. S., Artim-Esen B., Pekcelen Y., Inanc M.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS , cilt.29, sa.3, ss.303-309, 2010 (SCI-Expanded)

94. AB0413] THE DETERMINATION OF ANTI-TOPOISOMERASE I, ANTI-CENP-B AND ANTI-RNA POLYMERASE III AUTOANTIBODIES BY ELISA AND COMPARISON WITH CLINICAL PARAMETERS IN SYSTEMIC SCLEROSIS

Cagatay Y., Gurel-Polat N., Artim-Esen B., Kamali S., Gul A., Ocal L., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.2, 2010 (SCI-Expanded)

95. Predictors of Damage and Survival in Patients with Wegener's Granulomatosis: Analysis of 50 Patients

Kamali S., Erer B., Artim-Esen B., Gül A., Ocal L., Konice M., et al.

JOURNAL OF RHEUMATOLOGY , cilt.37, sa.2, ss.374-378, 2010 (SCI-Expanded)

96. Lupus nefriti tedavisinde mikofenolat mofetilin yeri

Artım Esen B.

RAED , cilt.1, ss.10-14, 2010 (Hakemli Dergi)

97. Amyloid arthropathy mimicking seronegative rheumatoid arthritis in multiple myeloma: case reports and review of the literature

Alpay N., Artim-Esen B., Kamali S., Gül A., Kalayoglu-Besisik S.

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS , cilt.16, sa.4, ss.226-231, 2009 (SCI-Expanded)

98. Seroreactivity against PTEN-induced putative kinase 1 (PINK1) in Turkish patients with Behçet's disease.

Vural B., Demirkan A., Ugurel E., Kalaylioglu-Wheeler Z., Esen B., Gure A. O., et al.

Clinical and experimental rheumatology , cilt.27, sa.2, 2009 (SCI-Expanded)

99. Antinükleer ve antifosfolipid antikoların klinik kullanımı

Artım Esen B.

Türkiye Klinikleri Dahili Tıp Bilimleri , cilt.2, sa.43, ss.26-33, 2006 (Hakemli Dergi)

100. Merkel-cell carcinoma arising after liver transplantation: A case report

Esen B., PINARBASI B., Buyukbabani N., Baykal C., Cizmeci O., Demir K., et al.

TRANSPLANTATION PROCEEDINGS , cilt.37, sa.10, ss.4413-4415, 2005 (SCI-Expanded)

101. Massive post-obstructive diuresis in a patient with Burkitt's lymphoma

ATAMER T., Artim-Esen B., YAVUZ S., ECDER T.

NEPHROLOGY DIALYSIS TRANSPLANTATION , cilt.20, sa.9, ss.1991-1993, 2005 (SCI-Expanded)

102. Sistemik Lupus Eritematozus Etyopatogenezinde Virüslerin Rolü

Artım Esen B.

İstanbul Tıp Fakültesi Dergisi , cilt.68, ss.85-91, 2005 (Hakemli Dergi)

103. Extrapulmonary sarcoidosis with chronic renal failure.

Erten N., Saka B., Artinesen B., Akif K., Kilicarslan I., Tascioglu C.

European journal of internal medicine , cilt.14, ss.262-264, 2003 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 240

1. Association of HLA Genes With Early Onset and Adult Systemic Lupus Erythematosus Disease in Turkish Population

Şentürk Çiftçi H., Şahin S., Kıvanç D., Doğan Ş., Mahmutbegoviç A., Demirbaş K. C., et al.

38th European Federation for Immunogenetics Congress, Praha, Çek Cumhuriyeti, 14 - 17 Mayıs 2025, cilt.105, ss.40-41, (Özet Bildiri)

2. Analysis of Relapses in a Single Center Cohort of Patients with Lupus Nephritis

Kemeç G., Varelci S., Gürel E., Kılıçaslan I., Özlük M. Y., Yalçınkaya Y., et al.

ACR Convergence 2024, Washington, Amerika Birleşik Devletleri, 14 - 19 Kasım 2024, cilt.76, ss.1343-1344, (Özet Bildiri)

3. BIOMARKERS OF DYSFUNCTIONAL HDL IN LUPUS NEPHRITIS AND ITS ASSOCIATION WITH SUBCLINICAL ATHEROSCLEROSIS

Zaralı S., Cingöz E., Çınar S., Baykız D., Poyanlı A., Bilge A. K., et al.

The European Alliance of Associations for Rheumatology, EULAR (2024), Vienna, Avusturya, 12 - 15 Haziran 2024, ss.1829, (Özet Bildiri)

4. The Relationship Between the NETosis Findings and Disease Activity in Behcet Disease

Bektaş E., Deniz R., Emrence Z., Sırma Ekmekci S., Abacı N., Amikishiyev S., et al.

ACR 2023, California, Amerika Birleşik Devletleri, 10 - 15 Kasım 2023, ss.4988-5002, (Özet Bildiri)

5. Behçet hastalığında oral ve sistemik hastalık aktivitesi ile netosis bulguları arasındaki ilişki

Bektaş E., Deniz R., Emrence Z., Sırma Ekmekci S., Abacı N., Amikishiyev S., et al.

23. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 11 - 15 Ekim 2023, ss.26, (Tam Metin Bildiri)

6. Aı̇levı̇ Akdenı̇z Ateşı̇ İle İlı̇şkı̇lı̇ Spondı̇loartrı̇t Daha Sık Ve Daha Erken Kalça Tutulumu Ve Kötü Prognozla İlı̇şkı̇lı̇dı̇r

BEKTAŞ M., SARI S., ÇETİN Ç., YALÇIN DULUNDU B. Ç., KOCA N., İNCE B., et al.

SPONDİLOARTRİTLER, İzmir, Türkiye, 21 - 24 Eylül 2023, ss.25-27, (Özet Bildiri)

7. Evaluatıon Of The Effıcacy And Complıcatıons Of Plasma Exchange In Anca- Assocıated Vasculıtıs: Results Of Propensıty Score Matchıng Analysıs In Hıgh-Rısk Patıents

İNCE B., BEKTAŞ M., ÇELİK B., YÜCE S., YALÇINKAYA Y., ARTIM ESEN B., et al.

ANNUAL EUROPEAN CONGRESS OF RHEUMATOLOGY 2023, 31 Mayıs - 03 Haziran 2023, (Özet Bildiri)

8. Extra-Axial Manifestations in Patients with Axial Spondyloarthritis: The Course and Response to Therapeutic Agents

Yılmaz A., Bektaş E., Canik A., Artım Esen B., İnanç M., Gül A., et al.

EULAR Congress 2023, Milan, İtalya, 31 Mayıs - 03 Haziran 2023, ss.1701, (Tam Metin Bildiri)

9. ABO Blood Groups and Increased Risk for Vascular Involvement in the Patients with Behçet’s Disease

Bektaş E., Büyükdemir A., Yalçınkaya Y., Artım Esen B., İnanç M., Gül A.

EULAR Congress 2023, Milan, İtalya, 31 Mayıs - 03 Haziran 2023, ss.1954, (Tam Metin Bildiri)

10. Efficacy and Safety of Interleukin-1 Blockers in Kidney Transplant Recipients with Familial Mediterranean Fever

Mirioğlu Ş., Dirim A. B., Bektaş M., Demir E., Tor Y. B., Yalçınkaya Y., et al.

17th BANTAO Congress, Antalya, Türkiye, 10 - 13 Kasım 2022, cilt.20, ss.54-55, (Özet Bildiri)

11. Behçet hastalığında ABO kan gruplarına göre vasküler tutulum riskinin değerlendirilmesi

Bektaş E., Büyükdemir A., Yalçınkaya Y., Artım Esen B., İnanç M., Gül A.

XXII. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 26 - 30 Ekim 2022, ss.115, (Özet Bildiri)

12. COVID-19 aşılaması sonrası yeni gelişen iki vaskülit olgumuzun literatür taramasıyla birlikte değerlendirilmesi

Alkaç B., Bektaş E., Tezel S., Denizmen D., Sarı S., Şanlı Y., et al.

XXII. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 26 - 30 Ekim 2022, ss.247, (Özet Bildiri) Sürdürülebilir Kalkınma

13. COVID-19 ve aşıları ile ilişkili rekürren perikardit olguları

Yılmaz A., Çetin O., Alagöz G., Atalar S. C., Amikishiyev S., Göksoy Solak Y., et al.

XXII. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 26 - 30 Ekim 2022, cilt.14, sa.89, ss.265, (Tam Metin Bildiri) Sürdürülebilir Kalkınma